nifedipine and clenbuterol

nifedipine has been researched along with clenbuterol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Béliveau, L; Calderone, A; Gardiner, PF; Murphy, RJ1
Denda, M; Fuziwara, S; Inoue, K1

Other Studies

4 other study(ies) available for nifedipine and clenbuterol

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1999, Volume: 221, Issue:3

    Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Body Weight; Calcium; Calcium Channels; Calcium Channels, L-Type; Cardiomegaly; Clenbuterol; Female; Heart; Hypertrophy; Male; Muscle Proteins; Muscle, Skeletal; Nifedipine; Organ Size; Rats; Rats, Sprague-Dawley

1999
Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption.
    The Journal of investigative dermatology, 2003, Volume: 121, Issue:1

    Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Biological Transport; Calcium; Calcium Channel Blockers; Calcium Channels; Clenbuterol; Epidermis; Humidity; Hyperplasia; Male; Mice; Mice, Hairless; Nifedipine; Procaterol; Propanolamines; Verapamil

2003